Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Veli‐Matti Kosma, Peter A. Fasching et al.|Breast Cancer Research|2015Cited by 24